| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.008 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.01 |